EP3160511
PROTEIN FORMULATIONS
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
15.6.2015EP published:
26.7.2023EP application number:
15738505.5
EPO information:
European Patent Register
Max expiry date:
14.6.2035
Title in English:
PROTEIN FORMULATIONSLanguage of the patent:
English
Timeline
Today
15.6.2015EP application
26.7.2023EP Publication
Owner
Name:
Amgen Inc.Address:
One Amgen Center Drive, Thousand Oaks, California 91320-1799, US
Inventor
Name:
PARK, SungaeAddress:
Thousand Oaks, California 91320, US
Name:
MCAULEY, Arnold J.Address:
Moorpark, California 93021, US
Priority
Number:
201462017560 PDate:
26.6.2014Country:
US
Classification
Categories:
A61K 38/18, A61K 47/20, A61P 7/06, A61P 37/02, A61K 47/26, A61K 9/19, A61K 47/18